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SUMMARY – Heart rate variability (HRV) gives information on the sympathetic-parasympa-
thetic autonomic balance. Th e aim of the study was to analyze sympathovagal balance after acute 
spinal cord injury (SCI), demonstrated by linear measures in time and frequency domain of HRV and 
to analyze the eff ect of corticosteroids on HRV parameters in SCI. Th e study included 40 tetraplegic 
patients with acute SCI and 40 healthy subjects as control group. In the SCI group, 29 patients 
 received and 11 patients did not receive corticosteroid therapy. All patients underwent 24-hour Holt-
er monitoring for evaluation of HRV. Cardiac autonomic balance was evaluated by analysis of HRV 
in time and frequency domain. Sympathovagal balance (LF/HF) was signifi cantly reduced in the 
groups of acute SCI patients, both with and without corticosteroid therapy, as compared with controls. 
However, there was no statistically signifi cant diff erence between the two SCI groups (1.74 (0524) 
with and 1.75 (0534) without corticosteroid therapy). Th is study showed the sympathovagal balance 
to be altered in the acute phase of cervical spinal cord trauma. Finally, there was no eff ect of cortico-
steroid therapy on HRV parameters in SCI patients.
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Introduction
Spinal cord injury (SCI) is an insult to the spinal 
cord resulting in a change, either temporary or perma-
nent, in the cord normal motor, sensory, or autonomic 
function1. One of the most debilitating secondary con-
sequences of SCI is alteration in autonomic cardiovas-
cular control that, combined with paralysis, predispos-
es individuals with SCI to a higher incidence of car-
diovascular disease. Th ey frequently exhibit arrhyth-
mias, refl ex bradycardia and cardiac arrest2.
Patients having sustained complete injury, with no 
motor function or sensation below the level of the spi-
nal cord lesion according to the American Spinal In-
jury Association (ASIA) standards3 have a much high-
er incidence of autonomic dysrefl exia (91% with com-
plete injury vs. 27% with incomplete injury). Auto-
nomic dysrefl exia (AD) can lead to sequels of 
cardiovascular eff ects, such as myocardial infarction, 
intracranial hemorrhage, and even death4.
Autonomic eff erent pathways of cardiovascular 
regulation are severely impaired in patients with tet-
raplegia. SCI with resultant quadriplegia is associated 
with signifi cant dysfunction of the sympathetic ner-
vous system. Sympathetic preganglionic neurons in 
the thoracic and upper lumbar segment of the spinal 
cord lose supraspinal control due to cervical SCI. Para-
sympathetic preganglionic fi bers passing through va-
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gal nerves, which originate from the brainstem, remain 
intact5.
Th e current ASIA standards for SCI assessment do 
not evaluate the severity of injury to autonomic path-
ways. Th e diagnosis of autonomic neuropathy depends 
on the results of tests that elicit refl ex changes in heart 
rate6. One of the best noninvasive markers of auto-
nomic nervous system function is analysis of the heart 
rate variability (HRV)7. Analysis of HRV has been 
used to assess autonomic function. It is altered in many 
diseases8-11. Th e parameters of HRV have been studied 
in patients with SCI and calculated from 24-hour 
Holter electrocardiogram (ECG)12,13.
Th e aim of this study was to analyze sympathova-
gal balance after acute SCI as demonstrated by linear 
measures in time and frequency domain and to com-
pare sympathovagal balance between tetraplegic pa-
tients administered and those not administered corti-
costeroid therapy. Th e aim was also to observe the ef-
fects of corticosteroids on HRV parameters.
Patients and Methods
Th e study included 40 patients (30 male and 10 fe-
male) with acute cervical SCI and 40 (31 male and 9 
female) healthy subjects matched for age and sex. In 
the SCI group, 29 patients received and 11 patients 
did not receive corticosteroid therapy. Inclusion crite-
ria were, as we previously reported14, age under 70, cer-
vical SCI with clinically complete motor and sensory 
loss under the level of injury, and sinus rhythm on 
ECG. Exclusion criteria were atrial fi brillation, AV 
block, diabetes mellitus, heart failure, and beta adren-
ergic blockers or antiarrhythmic drugs in therapy. 
None of the subjects had cardiopulmonary disease or 
used drugs that may infl uence HRV parameters.
Th e diagnosis of tetraplegia was made by neuro-
logical examination by a specialist according to the 
1996 ASIA standards3. It is based on neurological re-
sponses, touch and pinprick sensations tested in each 
dermatome, and strength of the muscles that control 
key motions on both sides of the body, including, 
shoulder shrug (C4), elbow fl exion (C5), wrist exten-
sion (C6), elbow extension (C7), fi nger fl exion (C8) 
and small fi nger abductors (Th 1), hip fl exion (L2), 
thigh adduction, extension of leg at the knee (L2, L3, 
L4), thigh abduction, dorsifl exion of foot, extension of 
toes (L4, L5, S1), extension of leg at the hip, plantar 
fl exion of foot and fl exion of toes (L5, S1, S2). Total 
paralysis of motor strength was considered as complete 
lesion. Anesthesia and analgesia were considered as 
complete lesion. Traumatic SCI is classifi ed into fi ve 
categories on the ASIA Impairment Scale. Th e current 
standards for assessment of SCI (ASIA) examination 
do not evaluate the severity of injury to autonomic 
pathways3.
Upon physical and radiographic examination to 
determine the degree and level of injury, some patients 
were administered anti-edematous therapy, as follows: 
methylprednisolone in high doses and 30 mg/kg bolus, 
followed by 5.4 mg/kg every hour. It is necessary to 
initiate treatment within 8 hours of injury and con-
tinue it for 23 hours15. Each subject provided a detailed 
medical history and all patients and controls were 
evaluated by physical examination and 24-hour Holter 
monitoring.
Analysis of HRV is a noninvasive and simple test 
to evaluate the autonomic nervous system function in 
patients with tetraplegia after SCI16.
Linear analysis of 24-hour ECG recording was 
performed on the fi rst day of hospital admission after 
acute SCI. Th e subjects were monitored with a 24-
hour high resolution ECG recorder. Holter ECGs 
were carefully analyzed by cardiologists. HRV analysis 
was assessed over 24 hours in time domain and with 
power spectral analyses. Most of the variables pro-
posed by the Task Force on the Heart Rate Variability 
were analyzed17.
Th e following time-domain and power spectral pa-
rameters were calculated: time domain analysis includ-
ed RR I – mean of R-R intervals; SDNN ms – stan-
dard deviation of all RR intervals; SDANN ms – stan-
dard deviation of the means of RR intervals in all 
5-minute segments of the entire recording; RMSSD 
ms – square root of the mean of the sum of the squares 
of diff erences between adjacent RR intervals; SDNN 
index ms – mean of the standard deviations of all RR 
intervals for all 5-minute segments of the entire re-
cording; SDSD ms – standard deviation of diff erences 
between adjacent RR intervals; NN50 count – number 
of pairs of adjacent RR intervals diff ering by more 
than 50 ms in the entire recording; and pNN50 – % 
NN50 count divided by the total number of all NN 
intervals.
Frequency domain analysis covered TP – total 
power; P – power; VLF – very low frequency (0.003-
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0.04 Hz); LF – low frequency (0.04-015 Hz); HF – 
high frequency (0.15-0.4 Hz); and LH/HF – low to 
high frequency ratio named sympathovagal balance. 
LF and HF variables are expressed in mse2. All vari-
ables were measured over 23.1-hour period. ECG re-
cordings were made by the CardioMem CM 3000 
(Getemed, G.E., Teltow, Germany) 6-channel Holter 
recorders. HRV was computer analyzed using the Car-
dioDay software.
R-R intervals that included ectopic beats were ex-
cluded and extrapolated by linear interpolation. Spec-
tral analysis was computed using fast Fourier transfor-
mation18.
Statistical analysis was performed using SPSS 17.5 
(SPSS Inc., New York, USA) in MS Windows 7.
Means ± standard deviation (SD) were calculated. 
Th e groups were compared by use of Mann-Whitney 
U test. Between group diff erences in time domain 
variables were assessed by Student’s t-test. Data were 
tested for normality using Kolmogorov-Smirnov dis-
tribution and Shapiro-Wilk test. Th e level of signifi -
cance was set at p<0.05.
Results
Heart rate variability data derived from 24-hour 
ECG recordings are shown in Tables 1 and 2.
Table 1 illustrates HRV data in frequency and time 
domain in SCI patients with and without corticoste-
roid therapy.
Table 1. Data obtained by analysis of 24-hour ECG recordings; HRV in the frequency 
and time domain in two SCI groups (with and without corticosteroid therapy)
Corticosteroid therapy
pYes No
HRV in frequency domain: X– SD X– SD
TP 1.6 (0.49) 1.4 (0.29) 0.254
p 1.6 (0.46) 1.7 (0.45) 0.385
VLF 1.7 (0.52) 1.8 (0.53) 0.860
LF 1.17 (0.249) 1.21 (0.145) 0.060
HF 3.38 (1.578) 2.94 (1.135) 0.550
LF/HF 1.74 (0.524) 1.75 (0.534) 0.858
HRV in time domain:
RR I 777.82 (92.56) 792.01 (50.93) 0.765
Median RR I 764.9 (101.08) 792.0 (63.02) 0.570
SDNN 92.7 (31.48) 99.6 (19.55) 0.241
SDANN 63.0 (23.08) 64.2 (16.76) 0.612
RMSSD 113.1 (34.07) 119.6 (33.00) 0.570
SDNN index 42.2 (13.79) 44.5 (14.42) 0.633
SDSD 58.6 (13.85) 63.5 (24.66) 0.765
NN50 22983.4 (13252.08) 21002.6 (7960.58) 0.829
pNN50 24.7 (10.78) 22.7 (7.39) 0.812
ECG = electrocardiography; HRV = heart rate variability; SCI = spinal cord injury; p = test of statistical sig-
nifi cance; values are expressed as mean ± standard deviation (SD); TP = total power; P = power; VLF = very 
low frequency; LF = low frequency; HF = high frequency; LF/HF = low to high frequency ratio; RR I = aver-
age value of R-R intervals; SDNN ms = standard deviation of all RR intervals; SDANN ms = standard de-
viation of the averages of RR intervals in all 5-minute segments of the entire recording; RMSSD ms = square 
root of the mean of the sum of the squares of diff erences between adjacent RR intervals; SDNN index ms = 
mean of the standard deviations of all RR intervals for all 5-minute segments of the entire recording; SDSD 
ms = standard deviation of diff erences between adjacent RR intervals; NN50 count = number of pairs of ad-
jacent RR intervals diff ering by more than 50 ms in the entire recording; pNN50 = % NN50 count divided by 
the total number of all NN intervals.
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Table 2 illustrates HRV data in frequency domain 
in SCI patients and control group.
In a previously published paper, we reported on the 
predominance of n. parasympathetic in SCI14. Time 
and frequency domain HRV indices were signifi cantly 
reduced in the SCI groups with and without cortico-
steroid therapy, as compared with controls. In the pres-
ent study, however, there was no statistically signifi cant 
diff erence between the two SCI groups.
Low frequency (LF) in the SCI group with corti-
costeroid therapy was lower (1.17 (0249)) than in the 
SCI patients without corticosteroid therapy (1.21 
(0145); p=0.060) but the diff erence did not reach sta-
tistical signifi cance. High frequency (HF) in the SCI 
group with corticosteroid therapy was higher (3.38 
(1578)) than in the group without corticosteroid ther-
apy (2.94 (1135); p=0.550) but not signifi cantly either. 
Th e sympathovagal balance, i.e. the low to high fre-
quency ratio (LF/HF) was not statistically signifi cant-
ly diff erent (p=0.858) between the two groups with 
cervical spine injuries.
All parameters monitored in time domain were not 
signifi cantly diff erent between the two groups with 
SCI. Analysis of the HRV parameters in time domain 
showed the standard deviation of average RR interval 
of fi ve-minute recording (SDANN) and standard de-
viation of all RR intervals (SDNN) as a measure of 
total HRV to be lower, but not signifi cantly, in the SCI 
group of patients having received corticosteroid thera-
py. Th e square root of the mean of the sum of the 
squares of diff erences between adjacent RR intervals 
(RMSSD) was also lower in the group having received 
corticosteroid therapy, while the number of adjacent 
RR intervals that diff ered by more than 50 ms (NN50) 
and the percentage of adjacent RR intervals that dif-
fered by more than 50 ms (pNN50) as measures of 
parasympathetic activity were higher in the SCI group 
having received corticosteroid therapy, but not signifi -
cantly either. Th ese results are contradictory, so further 
research is needed. However, there was no statistically 
signifi cant diff erence between the two SCI groups.
Discussion
Autonomic dysrefl exia is a potentially dangerous 
clinical syndrome that develops in individuals with 
SCI. Autonomic dysrefl exia develops in individuals 
with a neurologic level of SCI at or above the level of 
sixth thoracic vertebra. Th e severity and neurological 
level of SCI have major impact on the autonomic ner-
vous system function19. In individuals with intact cen-
tral and peripheral nervous systems, a noxious stimulus 
results initially in a sympathetic response, leading to 
elevation in heart rate and blood pressure primarily 
through spinal refl exes. Th is response is modulated by 
the central nervous system and peripheral barorecep-
tors through the parasympathetic nervous system; it 
results in heart rate and blood pressure control both 
through direct responses by the vagus nerve and 
through inhibitory spinal cord signals. An appropriate 
balance of sympathetic and parasympathetic outfl ow is 
attained and modulated by both the central and pe-
ripheral nervous systems20.
In tetraplegic individuals with complete lesions, 
disconnection of the spinal sympathetic neurons from 
cerebral control represents a unique possibility for 
analysis of the sympathetic infl uence on HRV19. Th e 
underlying pathophysiological changes that occur in 
the spinal cord and periphery causing autonomic dys-
refl exia have not been fully elucidated in a human 
model.
During the fi rst week after SCI, disorder of auto-
nomic functions can be life-threatening, especially due 
to development of bradycardia or even asystole. Cervi-
cal SCI has been associated with an increased risk of 
Table 2. Data obtained by analysis of 24-hour ECG 








X– SD X– SD
TP 1.6 (0.45) 3.8 (0.99) <0.001
P 1.6 (0.45) 3.0 (1.08) <0.001
VLF 1.7 (0.52) 2.7 (0.73) <0.001
LF 1.18 (0.224) 2.16 (0.228) <0.001
HF 3.26 (1.469) 1.28 (0.182) <0.001
LF/HF 0.41 (0.158) 1.71 (1.875) <0.001
ECG = electrocardiography; HRV = heart rate variability; SCI = 
spinal cord injury; p = test of statistical signifi cance; values are 
 expressed as mean ± standard deviation (SD); TP = total power; 
P = power; VLF = very low frequency; LF = low frequency; HF = 
high frequency; LF/HF = low to high frequency ratio.
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mortality from several cardiovascular diseases, includ-
ing both ischemic and non-ischemic heart disease21. 
Th erefore, rhythm disorders and conduct disorders as 
the most common cardiovascular complications are 
still a major cause of mortality after trauma to cervical 
spine and spinal cord.
Tetraplegic patients are deprived of supraspinal 
sympathoadrenal control, but have intact eff erent 
pathways. Interruption in the spinal cord of eff erent 
sympathetic pathways from central centers leads to 
pathologic changes in the activity of the peripheral 
sympathetic nervous system. In complete high-level 
SCI, functioning in the isolated spinal cord below the 
lesion becomes independent of supraspinal control 
and has been termed ‘decentralization’ of the sympa-
thetic nervous system5.
Recently developed methods may be particularly 
useful in evaluating function of autonomic nervous 
system and the eff ects of certain drugs on the cardio-
vascular function in individuals with SCI. Specifi cally, 
power spectral analysis of HRV has become common-
ly used as a noninvasive method to quantify autonom-
ic control of the cardiovascular system12. Permanent 
changes in the sympathetic and parasympathetic auto-
nomic nervous system cause changes in heart rate and 
fl uctuations in the average heart rate.
In our study, HRV was calculated from 24-hour 
Holter ECG, which is the optimal index of neural 
control of the heart12.
In a previously published paper, we have reported 
on the predominance of n. parasympathetic and al-
tered sympathovagal balance in acute SCI. In their 
study, Malmqvist et al. demonstrated a lower mean 
LF/HF ratio in the C1-T5 group as compared with 
the T6-T12 group, indicating that diminished sympa-
thetic activity in these patients results in lower values 
of LF, which could refl ect a less aff ected sympathova-
gal balance in the latter group. Th eir results were simi-
lar to ours, suggesting that LF is partly mediated by 
sympathetic fi bers, which supports the assumption 
that LF/HF ratio can serve as a measure of the sympa-
thovagal balance since HF is mediated entirely by va-
gal control19.
In high-level SCI, the sympathetic nervous system 
is disproportionately involved when compared with 
the parasympathetic nervous system5. However, the 
fact that LF is not absent after complete injury to cer-
vical spine suggests that the sympathetic control of the 
heart is modulated by rhythmic discharges by spinal 
sympathetic neurons, although without supraspinal 
control.
Previous studies on the eff ects of certain drugs on 
HRV did not provide defi nitive conclusions when 
HRV is directly related to the eff ect of certain medica-
tions. It is known that beta-receptor antagonists, an-
giotensin-converting enzyme inhibitors and angioten-
sin receptor blockers aff ect HRV and are not adminis-
tered without previous testing22-26. Th e antiarrhythmics 
propafenone and fl ecainide reduce HRV27.
Infl ammation can cause further damage to the spi-
nal cord and patients are treated with drugs to reduce 
swelling.
Th e National Acute Spinal Cord Injury Studies 
(NASCIS) II and III, and a Cochrane Database of 
Systematic Reviews article of all randomized clinical 
trials have verifi ed signifi cant improvement in motor 
function and sensation in patients with complete or 
incomplete SCI treated with high doses of methyl-
prednisolone within 8 hours of injury28,29.
We tried to see if corticosteroids had infl uence on 
HRV. Analysis of the HRV parameters in the time do-
main showed that SDANN and SDNN as measures of 
total HRV were slightly but not signifi cantly decreased 
in the group with SCI having received corticosteroid 
therapy as compared with the SCI group without ther-
apy. RMSSD was also decreased in the group on corti-
costeroid therapy, while NN50 and pNN50 as mea-
sures of parasympathetic activity were also slightly but 
not signifi cantly increased in the SCI group having 
received corticosteroid therapy.
Reduced HRV is associated with increased mor-
bidity and mortality. It can be assumed that reduced 
HRV could also be a predictor of morbidity and mor-
tality in subjects after trauma of the cervical spine30. 
Analysis of the HRV parameters in the frequency do-
main showed that low frequency was lower and high 
frequency higher in the SCI group on corticosteroid 
therapy as compared with the SCI group without cor-
ticosteroid therapy, but the diff erence did not reach 
statistical signifi cance. Th e low to high frequency ratio 
(LF/HF) did not diff er statistically signifi cantly 
(p=0.858) between the two SCI groups. Accordingly, 
analysis of the HRV parameters in the time and fre-
quency domains showed no signifi cant diff erence be-
tween the groups of SCI patients having and not hav-
ing received corticosteroid therapy.
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Stein et al. analyzed HRV in patients with system-
ic lupus erythematosus with and without corticoste-
roid treatment. Time and frequency domain HRV in-
dices were signifi cantly reduced in the systemic lupus 
erythematosus groups with and without corticosteroid 
therapy, as compared with controls. However, the indi-
ces were not signifi cantly diff erent between the two 
systemic lupus erythematosus groups31.
In conclusion, SCI causes dysfunction of the auto-
nomic cardiovascular regulation demonstrated by the 
spectral measures of HRV. Analysis of autonomic 
function is related to clinical measures of autonomic 
nervous system after acute SCI and provides a useful 
noninvasive clinical marker that can help assess the se-
verity of damage to the autonomic pathways. Th ese 
measures may also prove useful in evaluating changes 
in the autonomic function over time or due to inter-
ventions aimed at improving autonomic function after 
SCI and particularly in assessing the eff ects of certain 
drugs on the autonomic nervous system.
Finally, a high dose of methylprednisolone can im-
prove motor function and sensation in patients with 
complete or incomplete SCI28,29, but cannot improve 
the sympathovagal balance. We did not fi nd any ef-
fects of corticosteroids on HRV parameters. However, 
additional research is needed in the fi eld.
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Sažetak
UTJECAJ KORTIKOSTEROIDA NA VARIJABILNOST SRČANOGA RITMA 
KOD AKUTNE OZLJEDE VRATNE KRALJEŽNICE
A. Krstačić, G. Krstačić i D. Gamberger
Varijabilnost srčanoga ritma (VSR) daje informacije o simpatičko-parasimpatičkoj autonomnoj ravnoteži tijela. Cilj rada 
bio je analizirati simpatovagalnu ravnotežu nakon akutne ozljede vratne kralježnice prikazom rezultata VSR linearnim 
 metodama u vremenskoj i frekvencijskoj domeni te procijeniti učinak kortikosteroida na parametre VSR. Istraživanje je 
provedeno na 40 ispitanika s akutnom ozljedom vratne kralježnice i kralježnične moždine i 40 zdravih ispitanika kontrolne 
skupine. U skupini s ozljedom kralježnice 29 ispitanika je primalo kortikosteroidnu terapiju, a njih 11 nije primalo tu tera piju. 
U svih bolesnika provedeno je 24-satno praćenje Holterom za procjenu VSR. Analizom parametara VSR u vremenskoj i 
frekvencijskoj domeni praćena je autonomna kontrola srca. Simpatovagalna ravnoteža ukazala je na značajno snižen omjer 
niskih i visokih frekvencija (LF/HF) u bolesnika na kortikosteroidnoj terapiji i onih bez ove terapije zbog akutne ozljede 
vratne kralježnice u odnosu na kontrolnu skupinu. Međutim, nije bilo statistički značajne razlike između dviju skupina s 
ozljedom kralježnice [(1,74 (0524) u skupini na kortikosteroidnoj terapiji i 1,75 (0534) u skupini bez ove terapije]. Ovo 
istraživanje je pokazalo da je simpatovagalna ravnoteža poremećena kod bolesnika u akutnoj fazi traume vratne kralježnične 
moždine. Akutna ozljeda dovodi do poremećaja autonomne kardiovaskularne regulacije i modulacijske aktivnosti n. simpa-
tikusa na kardiovaskularni sustav. Međutim, nije nađen učinak kortikosteroida na paremetre VSR nakon akutne ozljede 
vratne kralježnice.
Ključne riječi: Vratna kralježnica – ozljede; Kralježnična moždina, ozljede; Srčani ritam; Adrenalni korteks, hormoni – terapi-
ja; Simpatički živčani sustav; Nervus vagus
